The application of shear and extensional viscosity measurements to assess the potential of hylan in viscosupplementation

被引:23
作者
AlAssaf, S [1 ]
Meadows, J [1 ]
Phillips, GO [1 ]
Williams, PA [1 ]
机构
[1] NE WALES INST, CTR WATER SOLUBLE POLYMERS, WREXHAM LL11 2AW, CLYWD, WALES
关键词
extensional viscosity; molecular weight; hylan; hyaluronan; viscosupplementation; viscoelasticity;
D O I
10.1016/0006-355X(96)00025-X
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The shear and extensional viscosity characteristics have been compared for hyaluronan and two samples of a cross-linked derivative, hylan, of different molecular weights, While shear thinning behavior was observed for all systems in shear flow, strain thickening was observed in extensional flow for the relatively dilute systems, However, there was a progressive transition to shear thinning behavior as the polymer concentration was increased, It is evident from the results that the shear flow techniques alone provide an incomplete picture of the rheological properties of these materials and that extensional flow characteristics are potentially dominant, For example, at relatively high deformation rates of 500 s(-1) and above, our results show that the extensional viscosities of aqueous solutions of the various polymers are at least two orders of magnitude greater than their corresponding shear flow viscosities. The incremental differences in viscosity with concentration increased with increasing molecular mass of the polymers and were greater in exensional flow than shear flow, These results demonstrate that the dynamic network structure formed by the higher molecular mass hylans offer potentially better physical and mechanical properties for visco supplementation of diseased osteoarthritis joints compared with the parent hyaluronan. Copyright (C) 1996 Elsevier Science Ltd
引用
收藏
页码:319 / 332
页数:14
相关论文
共 32 条
  • [1] ADAMS ME, 1993, J RHEUMATOL, V20, P16
  • [2] [Anonymous], 1994, TECHNIQUES RHEOLOGIC
  • [3] Balazs E A, 1968, Univ Mich Med Cent J, P255
  • [4] BALAZS EA, 1989, CIBA F SYMP, V143, P265
  • [5] BALAZS EA, 1993, J RHEUMATOL, V20, P3
  • [6] BALAZS EA, 1966, FED PROC, V25, P1813
  • [7] BALAZS EA, 1970, CHEMISTRY MOLECULAR, V3, P1241
  • [8] Balazs EA, 1985, J EQUINE VET, V5, P217, DOI [DOI 10.1016/S0737, DOI 10.1016/S0737-0806(85)80102-7]
  • [9] Balazs EA, 1989, CELLULOSICS UTILIZAT, P233
  • [10] BALAZS EA, 1984, OCULAR SURG NEWS, V15, P36